IP strategy for AI-assisted drug discovery
The IPKat
OCTOBER 31, 2024
If the patent application was filed too early it may not therefore cover the eventual clinical lead and worse, may become citable prior art against a subsequent filing. As patent law currently stands, pursuing a patent based solely on AI-modelling data would be a brave decision indeed.
Let's personalize your content